|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.39 USD | -1.00% |
|
-1.08% | -5.26% |
| 04:17pm | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 04-13 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.81x | 4.93x | 1.95x | 5.74x | 14.74x | 15.86x | 1.05% | 33.46B | ||
| 53.82x | 7.77x | 5.22x | 13.73x | 32.01x | 36.79x | -.--% | 166B | ||
| 30.87x | 2.5x | 1.13x | 5.87x | 18.28x | 20.23x | 0.69% | 141B | ||
| 26.31x | 3.32x | 1.05x | 4.54x | 15.18x | 15.95x | -.--% | 94.85B | ||
| 19.53x | 2.25x | 7.35x | 2.28x | 11.29x | 14.18x | 2.71% | 50.41B | ||
| 27.02x | 4.4x | 0.46x | 6.05x | 19.37x | 20.95x | -.--% | 45.09B | ||
| 15.41x | 2.71x | 2.38x | 1.78x | 9.63x | 11.19x | 0.22% | 34.07B | ||
| 23.08x | 4.4x | 1.63x | 4.73x | 16.39x | 17.94x | 0.85% | 34.02B | ||
| 28.64x | 2.53x | 3.86x | 5.72x | 18.07x | 20.3x | -.--% | 32.49B | ||
| 22.64x | 4.72x | 4.07x | 4.82x | 15.25x | 16.51x | 2.77% | 28.47B | ||
| 22.57x | 2.02x | 1.26x | 1.57x | 9.12x | 12.5x | 3.4% | 27.79B | ||
| 28.08x | 7.07x | -1.89x | 4.34x | 14.05x | 18.6x | -.--% | 19.93B | ||
| 28.21x | 2.3x | -0.62x | 1.75x | 10.72x | 18.84x | 1.89% | 10.99B | ||
| 31.97x | 1.39x | 0.77x | 4.16x | 13.53x | 14.86x | 0.3% | 10.45B | ||
| -11.57x | 2.32x | -0.01x | 2.09x | 11.55x | 13.86x | 0.61% | 6.07B | ||
| 47.48x | 7.87x | -0.95x | 5.23x | 23.28x | 34.26x | - | 3.97B | ||
| -273.64x | 2.71x | 3.14x | 6.6x | 62.28x | -170.13x | -.--% | 3.09B | ||
| 22.21x | - | 0.58x | - | - | - | -.--% | 3.02B | ||
| Average | 9.14x | 3.84x | 1.74x | 4.76x | 18.51x | 7.80x | 0.85% | 41.37B | |
| Weighted average by Cap. | 30.55x | 4.29x | 2.64x | 6.61x | 19.30x | 20.96x | 0.68% |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















